Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001523075 | SCV001732731 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2022-11-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488339 | SCV002803512 | likely benign | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2021-12-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004533947 | SCV004741012 | likely benign | CACNA1H-related disorder | 2019-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |